Inventor · disambiguated record
Srihari Gopal
Also filed as: GOPAL SRIHARI
15 granted patents·16 pending applications·62 citations·filing 2010–2025
90Inventor score
Files withJANSSEN PHARMACEUTICALS INC16JANSSEN PHARMACEUTICA NV13Janssen Pharmaceultica nv1LEWYN-BRISCOE PETER H1
Top patents by PatentIndex Score
31 records- 0196US11266627B1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Mar 8, 2022·12 cites·30 claims
- 0295US11998525B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Jun 4, 2024·5 cites·29 claims
- 0394US12150929B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Nov 26, 2024·2 cites·19 claims
- 0493US12161622B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Dec 10, 2024·2 cites·29 claims
- 0590US11324751B1Dosing regimens associated with extended release paliperidone injectable formulationsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted May 10, 2022·3 cites·18 claims
- 0690US11304951B1Dosing regimens associated with extended release paliperidone injectable formulationsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Apr 19, 2022·4 cites·26 claims
- 0789US10143693B2Dosing regimen for missed doses for long-acting injectable paliperidone estersJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Dec 4, 2018·31 cites·29 claims
- 0888US12419859B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Sep 23, 2025·0 cites·7 claims
- 0985US11666697B2Methods for ensuring resuspension of paliperidone palmitate formulationsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jun 6, 2023·3 cites·25 claims
- 1080US12171743B2Forms of aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Dec 24, 2024·0 cites·30 claims
- 1177US12201610B2Compositions comprising aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Jan 21, 2025·0 cites·19 claims
- 1277US2025326714A1Pure forms of crystalline aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1376US2025325515A1Forms Of AticaprantJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1475US11998524B2Forms of aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Jun 4, 2024·0 cites·44 claims
- 1568US12208100B2Dosing regimens associated with extended release paliperidone injectable formulationsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jan 28, 2025·0 cites·25 claims
- 1667US2025177350A1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1767US2023277500A1Compositions comprising aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1865US2023301573A1Methods of Identifying Schizophrenia Patients At Risk for RelapseJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1965US2022249495A1Dosing Regimens Associated With Extended Release Paliperidone Injectable FormulationsJanssen Pharmaceultica nv·Filed 2022·Application pending·0 cites
- 2062US2023241304A1Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 2161US2022193346A1Pre-filled syringe with optimized stopper placementJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2261US2023348377A1Pure forms of crystalline aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2359US2023085549A1Dosing Regimens Associated With Extended Release Paliperidone Injectable FormulationsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2459US2024238245A1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2559US2025228819A1Compositions comprising aticaprantJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2655US12472184B2Dosing regimens associated with extended release paliperidone injectable formulationsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 18, 2025·0 cites·26 claims
- 2752US11723569B2Methods of identifying schizophrenia patients at risk for relapseJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 15, 2023·0 cites·20 claims
- 2849US2018147210A1Dosing regimen associated with long acting injectable paliperidone estersJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 2946US2013331402A1Dosing regimen associated with long-acting injectable paliperidone estersJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 3045US2017128451A1Dosing regimen associated with long acting injectable paliperidone estersJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 3138US2011105536A1Dosing regimen associated with long-acting injectable paliperidone estersLEWYN-BRISCOE PETER H·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Srihari Gopal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →